Edition:
United Kingdom

Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

54.60USD
21 May 2019
Change (% chg)

$1.10 (+2.06%)
Prev Close
$53.50
Open
$53.93
Day's High
$54.72
Day's Low
$53.22
Volume
199,472
Avg. Vol
165,567
52-wk High
$57.99
52-wk Low
$31.98

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $2,652.00
Shares Outstanding(Mil.): 49.57
Dividend: --
Yield (%): --

Financials

  ARNA.OQ Industry Sector
P/E (TTM): 4.40 97.03 53.45
EPS (TTM): 12.15 -- --
ROI: 64.15 7.44 11.71
ROE: 68.14 7.90 16.35

Earnings vs. Estimates